Carbotextile Followed by Linvatinev Pembro for MS Stable Patients

Carbotextile followed by Linvatinev Pembro-Lizumab, it probably would win versus a three-drug regimen of carbotextile IO alone from trying to put the data together across trial comparison. I think IO perhaps with the VEGF inhibitor or the multi-turbitator syncinitis inhibitor is important. Let me just make that real simple. All the things we're not supposed to do, I would bet on carbotextle followed by Lin vatinev pembro lizumab right now.